NervGen Pharma Balance Sheet Health
Financial Health criteria checks 6/6
NervGen Pharma has a total shareholder equity of CA$18.8M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$31.8M and CA$13.0M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$30.30m |
Equity | CA$18.83m |
Total liabilities | CA$12.96m |
Total assets | CA$31.78m |
Recent financial health updates
We're Interested To See How NervGen Pharma (CVE:NGEN) Uses Its Cash Hoard To Grow
Jun 11Is NervGen Pharma (CVE:NGEN) In A Good Position To Invest In Growth?
Dec 22Here's Why We're Watching NervGen Pharma's (CVE:NGEN) Cash Burn Situation
Aug 30Will NervGen Pharma (CVE:NGEN) Spend Its Cash Wisely?
Apr 04We're Keeping An Eye On NervGen Pharma's (CVE:NGEN) Cash Burn Rate
Nov 23We Think NervGen Pharma (CVE:NGEN) Needs To Drive Business Growth Carefully
Jun 29Recent updates
We're Interested To See How NervGen Pharma (CVE:NGEN) Uses Its Cash Hoard To Grow
Jun 11Is NervGen Pharma (CVE:NGEN) In A Good Position To Invest In Growth?
Dec 22Here's Why We're Watching NervGen Pharma's (CVE:NGEN) Cash Burn Situation
Aug 30Will NervGen Pharma (CVE:NGEN) Spend Its Cash Wisely?
Apr 04NervGen Pharma Corp. (CVE:NGEN) Shares Could Be 31% Below Their Intrinsic Value Estimate
Feb 02We're Keeping An Eye On NervGen Pharma's (CVE:NGEN) Cash Burn Rate
Nov 23We Think NervGen Pharma (CVE:NGEN) Needs To Drive Business Growth Carefully
Jun 29We're Not Very Worried About NervGen Pharma's (CVE:NGEN) Cash Burn Rate
Mar 16We're Keeping An Eye On NervGen Pharma's (CVE:NGEN) Cash Burn Rate
Mar 08Financial Position Analysis
Short Term Liabilities: NGEN's short term assets (CA$31.1M) exceed its short term liabilities (CA$12.9M).
Long Term Liabilities: NGEN's short term assets (CA$31.1M) exceed its long term liabilities (CA$81.8K).
Debt to Equity History and Analysis
Debt Level: NGEN is debt free.
Reducing Debt: NGEN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NGEN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NGEN has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 28.6% each year.